Slide Set — Core Curriculum on Tuberculosis: What the Clinician Should Know
On December 9, 2011, CDC issued “Recommendations for Use of an Isoniazid–Rifapentine Regimen with Direct Observation to Treat Latent Mycobacterium tuberculosis Infection.” This document is in the process of being updated to reflect the new guidelines.
Addendum (PDF - 288kb)
Chapter 5: Treatment for Latent Tuberculosis Infection
Download complete Power Point Presentation (201 slides) – (20M)
![]() d |
![]() d |
![]() d |
![]() d |
![]() d |
![]() d |
![]() d |
![]() d |
![]() d |
![]() d |
![]() d |
![]() d |
![]() d |
![]() d |
![]() d |
![]() d |
![]() d |
![]() d |
![]() d |
![]() d |
![]() d |
![]() d |
![]() d |
NOTE: The slide set is in the public domain. You may reproduce these slides without permission. You are also free to adapt and revise these slides; however, you must remove the CDC name and logo if changes are made.

























